Drug intelligence / Profile preview

Neprinol

Development stage
Preclinical
Lead developer
Arthur Andrew Medical
Modality
Therapeutic Enzymes → Recombinant Proteins and Enzymes
Administration
Oral
01

Overview

Neprinol is a proprietary dietary supplement formulated as a blend of systemic and proteolytic enzymes, including serrapeptase, nattokinase, bromelain, papain, lipase, protease, rutin, and amla. Its primary aim is to support healthy fibrin levels in the body by promoting the breakdown of excess fibrin and unwanted proteins in the bloodstream. This action may help maintain normal blood viscosity and circulation while supporting joint health and immune function. The enzymes in Neprinol are thought to facilitate tissue repair by aiding in the removal of inflammatory factors and protein debris from blood vessels. The product is marketed for its potential benefits on cardiovascular health (by supporting proper blood flow), joint comfort (by modulating inflammation), immune system support (through clearing irritants), digestive health (via enhanced nutrient absorption), and overall well-being[1][2][4][5][7]. The mechanism centers on enzymatic degradation of fibrin—a key component in clot formation—thus potentially reducing abnormal clotting risk or excessive inflammation[5]. Key ingredients include: - **Serrapeptase:** A proteolytic enzyme with anti-inflammatory properties. - **Nattokinase:** A potent fibrinolytic enzyme that helps break down clots. - **Bromelain & Papain:** Enzymes that aid digestion and modulate inflammation. - **Lipase & Protease:** Support fat/protein digestion; may assist systemic effects. Neprinol is not an FDA-approved pharmaceutical drug but rather a dietary supplement intended for general wellness.

Brand names
NeprinolNeprinol Advanced Fibrin Defense
02

Targets

Fibrin (Factor Ia)

Beyond the preview

Go deeper on Neprinol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neprinol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call